Previous studies have revealed that up-regulation of CCL21 is a favorable prognostic factor in pancreatic cancer, renal cell carcinoma, colorectal cancer and BC, and represents a negative prognostic factor in bladder cancer and gastric cancer [49,53,54]. Here, CCL21 is linked to urinary bladder cancer.